New Mexico Educational Retirement Board Sells 500 Shares of HCA Healthcare Inc (NYSE:HCA)

New Mexico Educational Retirement Board reduced its stake in HCA Healthcare Inc (NYSE:HCA) by 2.2% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,900 shares of the company’s stock after selling 500 shares during the quarter. New Mexico Educational Retirement Board’s holdings in HCA Healthcare were worth $2,960,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Steward Partners Investment Advisory LLC raised its holdings in HCA Healthcare by 2.1% in the 2nd quarter. Steward Partners Investment Advisory LLC now owns 3,940 shares of the company’s stock worth $532,000 after acquiring an additional 82 shares during the last quarter. Cornerstone Advisors Inc. raised its holdings in HCA Healthcare by 15.0% in the 2nd quarter. Cornerstone Advisors Inc. now owns 675 shares of the company’s stock worth $91,000 after acquiring an additional 88 shares during the last quarter. Commonwealth Bank of Australia raised its holdings in HCA Healthcare by 3.6% in the 1st quarter. Commonwealth Bank of Australia now owns 2,883 shares of the company’s stock worth $374,000 after acquiring an additional 100 shares during the last quarter. Securian Asset Management Inc raised its holdings in HCA Healthcare by 0.4% in the 1st quarter. Securian Asset Management Inc now owns 27,942 shares of the company’s stock worth $3,643,000 after acquiring an additional 102 shares during the last quarter. Finally, CWM LLC raised its holdings in HCA Healthcare by 10.4% in the 1st quarter. CWM LLC now owns 1,181 shares of the company’s stock worth $154,000 after acquiring an additional 111 shares during the last quarter. 70.32% of the stock is currently owned by hedge funds and other institutional investors.

HCA traded down $0.96 during mid-day trading on Thursday, reaching $122.62. 27,440 shares of the company traded hands, compared to its average volume of 1,981,268. The stock has a market capitalization of $42.14 billion, a P/E ratio of 12.59, a P/E/G ratio of 1.07 and a beta of 0.85. HCA Healthcare Inc has a 52-week low of $110.31 and a 52-week high of $147.42. The company’s fifty day moving average price is $133.91 and its 200-day moving average price is $131.17.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 30th. The company reported $2.21 EPS for the quarter, missing the consensus estimate of $2.49 by ($0.28). The company had revenue of $12.60 billion during the quarter, compared to analysts’ expectations of $12.61 billion. HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter last year, the company earned $2.29 earnings per share. On average, research analysts forecast that HCA Healthcare Inc will post 10.36 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Tuesday, September 3rd will be paid a $0.40 dividend. The ex-dividend date is Friday, August 30th. This represents a $1.60 annualized dividend and a dividend yield of 1.30%. HCA Healthcare’s dividend payout ratio (DPR) is 16.38%.

A number of equities analysts recently weighed in on the stock. Goldman Sachs Group upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $147.00 to $160.00 in a report on Wednesday, July 10th. Stephens set a $150.00 price objective on shares of HCA Healthcare and gave the stock a “buy” rating in a report on Wednesday, August 7th. Zacks Investment Research lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 target price for the company. in a research note on Monday, May 27th. Deutsche Bank boosted their target price on shares of HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Finally, Mizuho set a $153.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, July 31st. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and seventeen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $153.35.

In other news, SVP Robert A. Waterman sold 33,786 shares of the company’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total value of $4,560,434.28. Following the completion of the sale, the senior vice president now directly owns 279,551 shares in the company, valued at approximately $37,733,793.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Patricia F. Elcan acquired 250 shares of HCA Healthcare stock in a transaction dated Tuesday, August 6th. The stock was bought at an average price of $124.10 per share, with a total value of $31,025.00. The disclosure for this purchase can be found here. Corporate insiders own 2.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: No Load Funds

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.